Resistance is futile: Codexis and the chase for low-cost cellulosic sugars
In California, Codexis yesterday announced a stunning 29% increase in revenue, to $107.1 million, driven by a 77% increase in sales of pharmaceutical products, from $18.6 million in 2009 to $32.8 million in 2010, and increases in collaborative R&D and government grants. With operating expenses growing by only 2 percent, the company swung from a […]